✦ LIBER ✦

845 PRECLINICAL CHARACTERISTICS OF ACH-3102: A NOVEL HCV NS5A INHIBITOR WITH IMPROVED POTENCY AGAINST GENOTYPE-1A VIRUS AND VARIANTS RESISTANT TO 1ST GENERATION OF NS5A INHIBITORS

✍ Scribed by G. Yang; J. Wiles; D. Patel; Y. Zhao; J. Fabrycki; S. Weinheimer; C. Marlor; J. Rivera; Q. Wang; V. Gadhachanda; A. Hashimoto; D. Chen; G. Pais; X. Wang; M. Deshpande; K. Stauber; M. Huang; A. Phadke

Book ID: 117381053
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(12)60857-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

876 ACH-3102, A SECOND GENERATION NS5A I

876 ACH-3102, A SECOND GENERATION NS5A INHIBITOR, DEMONSTRATES POTENT ANTIVIRAL ACTIVITY IN PATIENTS WITH GENOTYPE 1a HCV INFECTION DESPITE THE PRESENCE OF BASELINE NS5A-RESISTANT VARIANTS

✍ Muir, A.; Hill, J.; Lawitz, E.; Marbury, T.; Robarge, L.; Robison, H.; Hui, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Prevalence of hepatitis C virus variants

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

✍ Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Yuya Seko; Yusuke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Hepatitis C Virus NS5A Replication Compl

Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons

✍ Belema, Makonen; Nguyen, Van N.; Romine, Jeffrey L.; St. Laurent, Denis R.; Lope 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 931 KB